New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 13, 2012
09:08 EDTPRANPrana's PBT2 benefits on Huntington's Disease published
Prana Biotechnology announced that the Journal of Huntington's Disease has, in its December edition, published data showing the benefits of PBT2 in Huntington Disease. The paper describes PBT2's ability to inhibit the development of the symptoms and pathological features of Huntington Disease in pre-clinical transgenic animal models.
News For PRAN From The Last 14 Days
Check below for free stories on PRAN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 5, 2014
16:25 EDTPRANOn The Fly: Closing Wrap
Subscribe for More Information
10:28 EDTPRANHigh option volume stocks
Subscribe for More Information
September 4, 2014
18:50 EDTPRANPrana up 9.8% in after hours trading after receiving FDA orphan designation
Subscribe for More Information
18:06 EDTPRANPrana granted orphan status for treatment of Huntington disease
The FDA posted on its website that Prana Biotechnology has been granted orphan status for its treatment of Huntington's disease. Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use